Saba Capital Management, L.P.'s Form 4 filing
abrdn Life Sciences Investors (HQL) · filed Sep 17, 2025
- Accession no.
- 0001510281-25-000488
- Filed
- Sep 17, 2025
- Trade date
- Sep 15-16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $38.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saba Capital Management, L.P.CIK 0001510281 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | Common Stock | SSaleDisposed | −700 | $14.13 | −$9,891 | 2,952,807 | Indirect | |
| Sep 16, 2025 | Common Stock | SSaleDisposed | −2,026 | $13.99 | −$28,343.74 | 2,950,781 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.